2nd Quarter - Report — THE NICKLES GROUP, LLC for AMGEN (2026)

Firm

THE NICKLES GROUP, LLC

Client

AMGEN

Income

$60,000

Expenses

—

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Monitored implementation of P.L. 117-169, the Inflation Reduction Act as it relates to drug pricing. Issues related to biosimilars. Monitored issues related to cardiovascular health. Issues related to pharmacy benefit management. Monitored issues related to dialysis services. Issues related to the Most Favored Nation drug pricing.

Lobbyist	Covered position, as disclosed
BRETT BAKER	—
GREG D'ANGELO	—
MARY BETH SAVARY TAYLOR	—

Contacted: Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); Office of Management & Budget (OMB); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

Issues related to pharmacy benefit management. Issues related to cardiovascular care. Issues related to drug pricing. Issues related to the drug supply chain. S. 3788, Clear Labels Act. S. 3014, Ensuring Timely Access to Generics Act of 2025; S. 1954, Biosimilar Red Tape Elimination Act; S. 2658, Medication Affordability and Patent Integrity Act.

Lobbyist	Covered position, as disclosed
BRETT BAKER	—
GREG D'ANGELO	—
MARY BETH SAVARY TAYLOR	—

Contacted: Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE

Bills named: S. 2658 (119th), S. 1954 (119th), S. 3014 (119th), S. 3788 (119th)

Copyright/Patent/Trademark CPT

Monitored issues related to intellectual property.

Lobbyist	Covered position, as disclosed
JEFF CHOUDHRY	—
GREG D'ANGELO	—

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Taxation/Internal Revenue Code TAX

Monitored implementation of H.R. 1 (P.L. 119-21), One Big Beautiful Bill Act, as it relates to corporate taxes.

Lobbyist	Covered position, as disclosed
RACHEL JONES HENSLER	—

Bills named: H.R. 1 (119th)

Trade (domestic/foreign) TRD

Issues related to tariffs. Issues related to drug pricing.

Lobbyist	Covered position, as disclosed
MOLLY FROMM New	(continued) U.S. House Cmte on Oversight and Government Reform, Deputy General Counsel, Parliamentarian, Professional Staff Member; U.S. Rep. Darrell Issa, Leg. Asst., Leg. Corr., Staff Asst., Intern

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.